HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Shohet, J. M. Articles by Carroll, M. C. Search for Related Content PubMed PubMed Citation Articles by Shohet, J. M. Articles by Carroll, M. C. Social Bookmarking                      What's this?

J. Biol. Chem., Vol. 266, Issue 28, 18520-18524, 10, 1991

Localization of the human complement component C3 binding site on the IgG heavy chain

JM Shohet, L Bergamaschini, AE Davis and MC Carroll
Department of Pathology, Harvard Medical School, Boston, Massachusetts 02115.

The location of the covalent binding site of the third component of complement (C3) on the IgG heavy chain was determined by sequence analysis of peptides generated by cyanogen bromide digestion of C3-IgG adducts. Activation of the alternative pathway by incubation of heat- aggregated human IgG1 with fresh normal human plasma formed covalent adducts of C3b-IgG. CNBr peptides of these adducts were transferred to a polyvinylidene difluoride membrane, and amino-terminal sequences were determined. A 40-kDa dipeptide containing the covalent bond was identified by labeling the free thiol group (generated during activation of the internal thioester of C3b) with iodo[1-14C]acetamide and analyzed by amino acid sequencing. The resulting double sequence suggested an adduct with NH2 termini at residue 938 (pro-C3 numbering) of C3 (75 residues NH2-terminal to the thioester) and residue 84 in the variable region of the IgG heavy chain. These results combined with results from hydroxylamine treatment (splits ester linkage between C3b and IgG) imply that this adduct peptide consists of a 22-kDa C3 fragment and an 18-kDa IgG fragment. Therefore, C3 binds covalently within the region extending from the last 20 residues of the variable region through the first 20 residues of CH2.
CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    What's this?

This article has been cited by other articles:

				E. Jelezarova, A. Luginbuehl, and H. U. Lutz C3b2-IgG Complexes Retain Dimeric C3 Fragments at All Levels of Inactivation J. Biol. Chem., December 19, 2003; 278(51): 51806 - 51812. [Abstract] [Full Text] [PDF]

				A. D. Kennedy, M. D. Solga, T. A. Schuman, A. W. Chi, M. A. Lindorfer, W. M. Sutherland, P. L. Foley, and R. P. Taylor An anti-C3b(i) mAb enhances complement activation, C3b(i) deposition, and killing of CD20+ cells by rituximab Blood, February 1, 2003; 101(3): 1071 - 1079. [Abstract] [Full Text] [PDF]

				L. Vidarte, C. Pastor, S. Mas, A. B. Blazquez, V. de los Rios, R. Guerrero, and F. Vivanco Serine 132 Is the C3 Covalent Attachment Point on the CH1 Domain of Human IgG1 J. Biol. Chem., October 5, 2001; 276(41): 38217 - 38223. [Abstract] [Full Text] [PDF]